by University of Liverpool University of Liverpool researchers have published new estimates of the global burden of hepatitis D, and are calling for more efforts to tackle the ‘forgotten’ virus. In a study published in the Journal of Hepatology, Professor Anna Maria Geretti and Dr. Alexander Stockdale, in collaboration with researchers from the World Health...
Tag: <span>HIV</span>
Post
Link identified between dietary selenium and outcome of COVID-19 disease
by University of Surrey Publishing their findings in the American Journal of Clinical Nutrition, researchers using data (up to 18 February), investigated possible links between selenium levels in the body and cure or death rates of those with the COVID-19 virus in China. Selenium is an essential trace element obtained from the diet (i.e. fish,...
Post
New approach to curing HIV
New treatment method being tested in clinical study. Hamburg-based researchers are seeking to improve future treatment of HIV patients using a new gene and cell method. Under the umbrella of Hamburg biotech startup Provirex, they are developing a new therapeutic approach that uses ‘gene scissors’ to cut out the blueprint of the AIDS pathogen HIV...
Post
Neurologists watch for signs that COVID-19 can attack the brain
Neurologists at the University of Alberta are monitoring Edmonton patients diagnosed with COVID-19 for signs that the virus, which can cause deadly respiratory illness, may also attack the brain. “Several manuscripts have been published that suggest patients with severe COVID-19 symptoms also display neurological problems such as confusion, stroke-like attacks, even a hemorrhage in the...
Post
Four-Drug Combination Effective Long-Term for HIV Suppression
NEW YORK (Reuters Health) – The single-tablet combination of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) is effective for long-term viral suppression in previously untreated patients with HIV-1 infection, according to 96-week results from the AMBER trial. Week 48 primary analyses of the AMBER trial and the companion EMERALD trial showed that D/C/F/TAF had high, noninferior antiviral efficacy with...
Post
Study identifies potential drug treatments for telomere diseases
April 22, 2020 — A new qualitative study by researchers at Columbia University Mailman School of Public Health found that the majority of women living with HIV would endorse a monthly long acting injectable (LAI) antiretroviral therapy over current daily pills. LAI HIV therapy has completed Phase III trials and is awaiting Food and Drug...
Post
The Lancet HIV: Study suggests a second patient has been cured of HIV
Long-term follow-up of the London patient suggests no detectable active HIV virus remains in the patient. THE LANCET Long-term follow-up of the London patient suggests no detectable active HIV virus remains in the patient. Although the treatment is high-risk and only suitable for certain patients, the results provide evidence that this patient is the second...
Post
Drinking weakens bones of people living with HIV: study
For people living with HIV, any level of alcohol consumption is associated with lower levels of a protein involved in bone formation, raising the risk of osteoporosis, according to a new study by researchers from the Boston University School of Public Health (BUSPH) and School of Medicine (BUSM) and published in the journal Alcoholism: Clinical...
Post
What the discovery of a new HIV strain means for the pandemic
by Linda-Gail Bekker, The Conversation The discovery of a rare new strain of HIV for the first time in nearly 20 years recently made headlines around the world. The big question is what the discovery means for the overall response to the HIV epidemic. A team of US researchers from Abbott, an American medical devices...
Post
Single dose of antibodies can knock out HIV in newborns
Combination of 2 antibodies taken 30 hours after virus exposure prevents infection in baby monkeys Date:January 7, 2020 Source:Oregon Health & Science University Summary:A single dose of an antibody-based treatment can prevent HIV transmission from mother to baby, new nonhuman primate research suggests for the first time. This is the first time a single dose of broadly neutralizing antibodies given after viral exposure has been found to prevent infection...